Preterm Birth: Clinical Trials

21 trials for Preterm Birth, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

21 completed. 21 Phase 3, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 321Completed 21
Phase 23Completed 3

Follow Preterm Birth: new trials by email Literature Review of Preterm Birth trials Research Report on Preterm Birth

Trials (filtered) newest first · largest first

All 21 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Effect of Low Doses of Prednisone on the Prolongation of Pregnancy in Threatened Preterm Birth
Prednisone 5Mg - Preterm Birth
Phase 2 / Phase 3CompletedUniversity of Mostar262023-11-082025-02-19
To Optimize Antenatal Management of Women With Pre Term Labor Using Amniocentesis
Steroid Drug, Tocolytic Agents - Preterm Birth, Preterm Labor
Phase 3CompletedFundacion Clinic per a la Recerca Biomédica2472021-05-052025-03-12
Surfactant Nebulization for the Early Aeration of the Preterm Lung
Surfactant nebulisation - Preterm Birth, Respiratory Distress Syndrome
Phase 3CompletedUniversity of Zurich322021-03-192024-07-08
Single Dose Antenatal Corticosteroids (SNACS) for Women at Risk of Preterm Birth
12 mg betamethasone + placebo, 24 mg betamethasone - Preterm Birth, Complication of Prematurity
Phase 3CompletedMcMaster University302021-03-012023-08-23
Comparison Between Vaginal Pessary and Progestogen in Twin Pregnancy With Short Cervical Length
Micronised vaginal progesterone, Vaginal pessary - Preterm Birth
Phase 3CompletedNational University of Malaysia1422019-10-012024-01-23
Effect of Early Use of Caffeine Citrate in Preterm Neonates
Caffeine Citrate - Preterm Birth
Phase 3CompletedAin Shams University542019-04-052019-07-02
Assessment of DHA On Reducing Early Preterm Birth
Docosahexaenoic acid - 800mg/day, Docosahexaenoic acid - 200mg/day, Placebo - Preterm Birth
Phase 3CompletedUniversity of Kansas Medical Center11002016-06-082021-03-30
Vaginal Progesterone in Twin With Short Cervix
Progesterone, Placebo - Preterm Birth, Twin Dichorionic Diamniotic Placenta
Phase 3CompletedAin Shams University1442016-04-052020-05-20
Pessary in Singleton Gestations With Short Cervix Without Prior Preterm Birth
Cervical pessary - Preterm Birth
Phase 3CompletedFederico II University3002016-03-012018-06-18
A Randomized Clinical Trial of Oral Magnesium Supplementation in Pregnancy
Magnesium citrate - Magnesium Deficiency, Preterm Birth
Phase 3CompletedProfessor Fernando Figueira Integral Medicine Institute30002014-03-012020-07-23
Progesterone Vaginal Pessary for Prevention of Preterm Twin Birth
The progesterone vaginal pessary, Tonics group - Preterm Birth
Phase 2 / Phase 3CompletedAssiut University1002014-02-012017-01-24
Antenatal Late Preterm Steroids (ALPS): A Randomized Placebo-Controlled Trial
Betamethasone, Placebo - Pregnancy, Respiratory Distress Syndrome
Phase 3CompletedThe George Washington University Biostatistics Center28312010-10-012023-03-28
Confirmatory Study of 17P vs Vehicle for Prevention of Preterm Birth in Women w/ Previous Spontaneous Preterm Delivery
Hydroxyprogesterone Caproate Injection (HPC), 250mg/mL, Vehicle - Preterm Birth
Phase 3CompletedAMAG Pharmaceuticals, Inc.17402009-10-012022-06-01
Randomized Study of Pessary Versus Standard Management in Women With Increased Chance of Premature Birth
Vaginal pessary (CE0482, MED/CERT ISO 9003 / EN 46003) - Preterm Birth
Phase 3CompletedKing's College Hospital NHS Trust21092008-08-012021-02-12
Antenatal Micronutrient Supplementation and Infant Survival
Iron (27 mg) - folic acid (600 ug), Multiple micronutrient - Infant Mortality, Preterm Birth
Phase 3CompletedJohns Hopkins Bloomberg School of Public Health445672008-01-012022-10-19
Oral Progesterone for Prevention of Preterm Birth
oral micronized progesterone, Identical Placebo tablet - Preterm Birth
Phase 3CompletedFetal Medicine Foundation362006-11-012019-02-18
Natural Progesterone and Preterm Birth in Twins
200 mg of Progesterone, 400 mg Progesterone, Placebo - Preterm Birth
Phase 3CompletedInstituto Valenciano de Infertilidad, IVI VALENCIA2902006-01-012013-04-04
Omega-3 Fatty Acid Supplementation to Prevent Preterm Birth in High Risk Pregnancies
17 alpha-Hydroxyprogesterone Caproate and Omega-3 supplement, 17 alpha-hydroxy progesterone caproate and Placebo supplement - Preterm Birth
Phase 3CompletedThe George Washington University Biostatistics Center8002005-02-012019-07-12
17OHP for Reduction of Neonatal Morbidity Due to Preterm Birth (PTB) in Twin and Triplet Pregnancies
17-alpha-hydroxyprogesterone caproate injectable, Placebo - Preterm Birth
Phase 2 / Phase 3CompletedObstetrix Medical Group3212004-11-012016-04-11
Trial of Progesterone in Twins and Triplets to Prevent Preterm Birth (STTARS)
17 alpha-hydroxyprogesterone caproate (17P) - Preterm Birth, Pregnancy
Phase 3CompletedThe George Washington University Biostatistics Center7952004-04-012019-02-21

Showing 20 of 21. Sign in to see all of them.

Narrower conditions

Premature Birth (21)  ·  Obstetric Labor, Premature (2)  ·  Respiratory Distress Syndrome (2)  ·  Infant Death (1)  ·  Magnesium Deficiency (1)  ·  Malnutrition (1)  ·  Neoplasm Metastasis (1)  ·  Obstetric Labor Complications (1)  ·  Perinatal Death (1)  ·  Pregnancy Complications (1)  ·  Pulmonary Atelectasis (1)

Broader conditions

Female Urogenital Diseases and Pregnancy Complications (21)  ·  Urogenital Diseases (21)  ·  Obstetric Labor Complications (20)  ·  Pregnancy Complications (20)  ·  Obstetric Labor, Premature (19)  ·  Lung Diseases (2)  ·  Nutrition Disorders (2)  ·  Nutritional and Metabolic Diseases (2)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Respiration Disorders (2)  ·  Respiratory Tract Diseases (2)  ·  Death (1)  ·  Deficiency Diseases (1)  ·  Malnutrition (1)

Interventions

17 alpha-Hydroxyprogesterone Caproate (3)  ·  Progesterone (3)  ·  Betamethasone (2)  ·  Pessaries (2)  ·  Utrogestan (2)  ·  17-alpha-Hydroxyprogesterone (1)  ·  Adrenal Cortex Hormones (1)  ·  Docosahexaenoic Acids (1)  ·  Folic Acid (1)  ·  Iron (1)  ·  Prednisone (1)  ·  Saline Solution (1)  ·  Tocolytic Agents (1)  ·  caffeine citrate (1)  ·  magnesium citrate (1)

Sponsors

The George Washington University Biostatistics Center (3)  ·  Ain Shams University (2)  ·  King's College Hospital NHS Trust (2)  ·  AMAG Pharmaceuticals, Inc. (1)  ·  Assiut University (1)  ·  Federico II University (1)  ·  Fetal Medicine Foundation (1)  ·  Fundacion Clinic per a la Recerca Biomédica (1)  ·  Instituto Valenciano de Infertilidad, IVI VALENCIA (1)  ·  Johns Hopkins Bloomberg School of Public Health (1)  ·  McMaster University (1)  ·  National University of Malaysia (1)  ·  Obstetrix Medical Group (1)  ·  Professor Fernando Figueira Integral Medicine Institute (1)  ·  University of Kansas Medical Center (1)

Countries

United States (8)  ·  Spain (4)  ·  Brazil (3)  ·  Italy (3)  ·  Canada (2)  ·  Chile (2)  ·  Egypt (2)  ·  United Kingdom (2)  ·  Austria (1)  ·  Bangladesh (1)  ·  Bosnia and Herzegovina (1)  ·  Bulgaria (1)  ·  Colombia (1)  ·  Czechia (1)  ·  Germany (1)

Top investigators

Andrew Combs, MD (1)  ·  Bassem El Sayed (1)  ·  Cynthia Gyamfi Bannerman, MD (1)  ·  David S McKenna, MD (1)  ·  Dwight Rouse, MD (1)  ·  Elizabeth A Thom, Ph.D. (1)  ·  Elizabeth A Thom, PhD (1)  ·  Hisham Awad (1)  ·  Joao G Alves, PhD (1)  ·  Keith P West, Jr. (1)  ·  Kellie Murphy, MD, MSc, FRCSC (1)  ·  Kimberly Maurel, RN, MSN, CNS (1)  ·  Kypros H Nicolaides, MD, PhD (1)  ·  Kypros H Nicolaides, Professor (1)  ·  Margaret Harper, MD (1)

Results publications

PMID 17671253, PMID 17671254, PMID 19155896, PMID 19716543, PMID 20093894, PMID 21173653, PMID 21508745, PMID 21620357, PMID 23635681, PMID 25005784, PMID 25425377, PMID 25536256, PMID 25985774, PMID 26186135, PMID 26431336, PMID 26842679, PMID 27604769, PMID 27769295, PMID 28193189, PMID 29260226, PMID 31006806, PMID 31652479, PMID 32147290, PMID 32272914, PMID 32316938, PMID 32844185, PMID 33368142, PMID 34308309, PMID 34588268, PMID 34941552, PMID 35155983, PMID 35398844, PMID 35618748, PMID 36424125, PMID 36680919, PMID 37806075, PMID 38032260, PMID 39062451, PMID 39145520, PMID 40653272, PMID 42848825

NIH funding

U10HD021410 (2), U10HD027869 (2), U10HD027915 (2), U10HD027917 (2), U10HD034208 (2), U10HD036801 (2), U10HD040485 (2), U10HD040500 (2), U10HD040512 (2), U10HD040544 (2), U10HD040545 (2), U10HD040560 (2), U01HL098354 (1), U01HL098554 (1), U10HD027860 (1)